Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
Wall Street is rotating fast as AI fears hit software stocks. With tech sliding, investors are shifting toward cyclicals, value and old-economy leaders.
Hedge funds rebound with strong returns as volatility and higher rates revive active strategies, but rising correlations raise doubts about whether managers are delivering true diversification or alpha.
Bitcoin rose about 12% in a single day to reclaim the $70,000 level, even as market sentiment remained in Extreme Fear territory and roughly $2 billion in leveraged positions were liquidated.
Will SpaceX make Elon Musk the first trillionaire? Polymarket traders are betting a mid-2026 IPO could push Musk past Rockefeller and Mansa Musa in the history books.
Hyperscalers entering new phase of aggressive AI spending, with MSFT standing out for cash flow resilience while AMZN faces investor pressure over capex plans. MSFT free cash flow most resilient, peers trending towards negative.
Bitcoin (CRYPTO: BTC) has fallen about 15% over the past week and more than 20% over the past month, prompting questions about what's driving the decline and how much
Infleqtion, formerly ColdQuanta, is an under-the-radar quantum computing and sensing company set to go public in the coming weeks via SPAC merger with well-known Wall Street dealmaker Michael Klein's Churchill Capital Corp X (NASDAQ:CCCX).
Roivant shares surged after its skin disease drug brepocitinib showed strong Phase 2 results, with high response rates, early benefits, and no serious safety issues.
uniQure shares early trial data showing strong enzyme increases in Fabry patients, manageable safety results, and paused higher dosing after liver enzyme findings.
Novo Nordisk stock rose Friday after the FDA warned against illegal copycat weight loss drugs, following concerns over Hims & Hers' compounded semaglutide pill and weaker 2026 sales guidance.
Centene stock fell after mixed 2026 guidance, with strong revenue growth offset by a weaker sales outlook, higher medical costs, and declining Medicaid membership.
XRP (CRYPTO: XRP) surged 25% after Ripple outlined a growing set of “institutional DeFi” building blocks on the XRP Ledger designed to make the network via
Gold and silver prices rebound after plunge, experts say no fundamental breakdown. Market volatility driven by liquidity, leverage, and geopolitical tension. Buy on dip: AEM, HL, SLV.
NatWest shares rose after the bank announced an exclusive mortgage partnership with Rightmove aimed at boosting digital homebuying and first-time buyer access.
